Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilbert Zwart

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
EMBO Reports|December 20, 2021
Unexpected gene activation following CRISPR-Cas9-mediated genome editingAnna G Manjón, Simon Linder, Hans Teunissen, et al.
Clinical Pharmacokinetics|May 6, 2015
Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of TamoxifenAurelia H M de Vries Schultink, Wilbert Zwart, Sabine C Linn, et al.
The Journal of Cell Biology|July 1, 2009
Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioningNuno Rocha, Coenraad Kuijl, Rik van der Kant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical ResponsesLaurel M Schunselaar, Josine M M F Quispel-Janssen, Yongsoo Kim, et al.
Journal of Mammary Gland Biology and Neoplasia|November 16, 2019
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in MiceLisette M Cornelissen, Linda Henneman, Anne Paulien Drenth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2018
Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug ConjugatesLaurel M Schunselaar, Kim Monkhorst, Vincent van der Noort, et al.
Cancer Research|July 17, 2014
USP9X downregulation renders breast cancer cells resistant to tamoxifenHendrika M Oosterkamp, E Marielle Hijmans, Thijn R Brummelkamp, et al.
NPJ Systems Biology and Applications|February 21, 2024
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory propertiesMaisa N G van Genderen, Jeroen Kneppers, Anniek Zaalberg, et al.
Nature Biotechnology|January 12, 2016
Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9Gozde Korkmaz, Rui Lopes, Alejandro P Ugalde, et al.
Genomics Data|March 17, 2016
Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancerEkaterina Nevedomskaya, Suzan Stelloo, Henk G van der Poel, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
EMBO Reports|December 20, 2021
Unexpected gene activation following CRISPR-Cas9-mediated genome editingAnna G Manjón, Simon Linder, Hans Teunissen, et al.
Clinical Pharmacokinetics|May 6, 2015
Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of TamoxifenAurelia H M de Vries Schultink, Wilbert Zwart, Sabine C Linn, et al.
The Journal of Cell Biology|July 1, 2009
Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioningNuno Rocha, Coenraad Kuijl, Rik van der Kant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical ResponsesLaurel M Schunselaar, Josine M M F Quispel-Janssen, Yongsoo Kim, et al.
Journal of Mammary Gland Biology and Neoplasia|November 16, 2019
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in MiceLisette M Cornelissen, Linda Henneman, Anne Paulien Drenth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2018
Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug ConjugatesLaurel M Schunselaar, Kim Monkhorst, Vincent van der Noort, et al.
Cancer Research|July 17, 2014
USP9X downregulation renders breast cancer cells resistant to tamoxifenHendrika M Oosterkamp, E Marielle Hijmans, Thijn R Brummelkamp, et al.
NPJ Systems Biology and Applications|February 21, 2024
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory propertiesMaisa N G van Genderen, Jeroen Kneppers, Anniek Zaalberg, et al.
Nature Biotechnology|January 12, 2016
Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9Gozde Korkmaz, Rui Lopes, Alejandro P Ugalde, et al.
Genomics Data|March 17, 2016
Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancerEkaterina Nevedomskaya, Suzan Stelloo, Henk G van der Poel, et al.
Pageof 18